DEIR EZZOR PROVINCE, SYRIA - The US-backed Syrian Democratic Forces expect a fierce battle with Islamic State in Iraq and Syria militants who are still holed up in the group's last enclave in eastern Syria, Mustafa Bali, the head of the SDF media office, told Reuters on Friday .
But Bali said ISIS militants were still holed up in Baghuz, a village on the Iraqi border, and had not surrendered, and there were still civilians in the enclave. The SDF will evacuate another large group of civilians on Friday, he said. The ISIS enclave at Baghuz, a tiny area on the eastern bank of the Euphrates River, is the last populated territory held by the Islamists, who have been steadily driven by an array of enemies from swathes of land they once held.
The numbers of evacuees pouring out of Baghuz have surpassed initial estimates of how many were inside.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
US-backed SDF expects fierce battle in final IS enclaveBAGHOUZ, Syria: US-backed Syrian fighters said on Friday (Mar 1) they expect a fierce battle with Islamic State militants still holed up in their ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
US housing outlook stuck in a lull as economy dulls: Reuters pollU.S. house prices are forecast to rise this year at the slowest pace in more than half a decade, as a dearth of single-family homes and higher ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
US-backed Syrian force says advances into final ISIS enclaveDEIR EZZOR, SYRIA (REUTERS) - The US-backed Syrian Democratic Forces (SDF) have advanced into Islamic State in Iraq and Syria's (ISIS) final territorial enclave, where heavy fighting is under way, the SDF media office said on Friday (March 1).. Read more at straitstimes.com.
Source: The Straits Times - 🏆 8. / 63 Read more »
US-backed force expects 'decisive battle' against ISIS in SyriaNEAR BAGHOUZ, Syria (REUTERS) - The US-backed Syrian force closing in on the ISIS' last territorial bastion near the Iraqi border expects a 'decisive battle' on Sunday (March 3) after advancing slowly, a spokesman said overnight.. Read more at straitstimes.com.
Source: The Straits Times - 🏆 8. / 63 Read more »
Microsoft workers demand it drop US$480m US Army contract[SAN FRANCISCO] Several Microsoft Corp employees on Friday demanded that the company cancel a US$480 million hardware contract with the US Army and stop developing 'any and all weapons technologies.' Read more at The Business Times.
Source: BusinessTimes - 🏆 15. / 51 Read more »
Novartis gene therapy is cost effective at up to US$900,000: US groupAn experimental gene therapy for spinal muscular atrophy (SMA) developed by Swiss drugmaker Novartis AG would offer value at a price of US$310,000 ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Microsoft workers demand it drop US$450 million US Army contractSeveral Microsoft Corp employees on Friday demanded that the company cancel a US$480 million hardware contract with the U.S. Army and stop ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
US: Wall St trims gains as US, China struggle over gaps in trade issues[NEW YORK] US stocks were higher in afternoon trading on Friday but pared gains after US officials said the United States and China still have issues to resolve in their ongoing trade talks. Read more at The Business Times.
Source: BusinessTimes - 🏆 15. / 51 Read more »
Oil hits 2019 highs on US-China trade hopes, but US output weighs[NEW YORK] Oil prices touched their highest since mid-November on Friday and posted weekly gains for the second week in a row, boosted by hopes that US-China trade talks would soon produce a deal, although new record US oil supply limited gains. Read more at The Business Times.
Source: BusinessTimes - 🏆 15. / 51 Read more »
Novartis gene therapy would be cost effective up to US$900,000: US groupAn experimental gene therapy for spinal muscular atrophy (SMA) developed by Swiss drugmaker Novartis AG would offer value at a price of US$310,000 ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »